Ampio Pharmaceuticals Inc
Change company Symbol lookup
Select an option...
AMPE Ampio Pharmaceuticals Inc
IKNX Ikonics Corp
UTX United Technologies Corp
KR Kroger Co
$TBK.TC iSHR LEH TIPS TC
NFLX Netflix Inc
MLM Martin Marietta Materials Inc
HUBS HubSpot Inc
SBUX Starbucks Corp
VIOT Viomi Technology Co Ltd
Go

Health Care : Pharmaceuticals | Small Cap Blend
Company profile

Ampio Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused primarily on the development of therapies to treat prevalent inflammatory conditions for which there are limited treatment options. The Company's two lead product candidates in development are Ampion for osteoarthritis of the knee and Optina for diabetic macular edema. Ampion is a sub 5000 molecular weight fraction of commercial human serum albumin (HSA). Optina is a low-dose formulation of danazol. The Ampio segment consists of its biopharmaceuticals compounds and the clinical trials associated with them. The Company is primarily developing compounds that decrease inflammation by inhibiting specific pro-inflammatory compounds by affecting specific pathways at the protein expression and at the transcription level; activating specific phosphatase or depleting available phosphate needed for the inflammation process, and decreasing vascular permeability.

Closing Price
$0.53
Day's Change
0.115 (27.71%)
Bid
--
Ask
--
B/A Size
--
Day's High
0.5829
Day's Low
0.45
Volume
(Heavy Day)
Volume:
9,585,398

10-day average volume:
2,449,755
9,585,398

Vulcan Materials started at hold with $166 stock price target at Deutsche Bank

7:39 am ET November 21, 2019 (MarketWatch)
Print

(END) Dow Jones Newswires

November 21, 2019 07:39 ET (12:39 GMT)

Copyright (c) 2019 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.